Diet plays a very important role when it comes to your health. There are many people who have to adhere to strict diets because of certain conditions they have. While the basic understanding that we need all kinds of foods to fulfill our body’s needs, sometimes these foods can also cause harm to your body. For example, lactose intolerant people cannot eat or consume any kind of dairy product as their bodies do not have the necessary compounds, known as lactose, to break down dairy foods. Similarly, there are many foods that may be ok for others to consume, but not for people who have digestive issues like IBS. But this new clinical trial may be able to help us know what food we can eat based on our blood test! The blood test, called inFoods IBS, looks for a special type of antibody in the blood. Antibodies are like tiny soldiers that our bodies make to fight off things that could make us sick.
IBS is a very common problem, affecting a large number of people. Many people know that what they eat can make their IBS symptoms worse, but it's often hard to figure out exactly which foods are the culprits. This is because everyone is different, and what triggers one person might not trigger another. Doctors hear from patients all the time, asking for help in determining which foods are causing their problems. So, finding a reliable way to pinpoint those foods is important. This test is attempting to provide that reliability.
Basically, the test is looking for an antibody called IgG. When the gut reacts badly to a food, it makes more of this IgG antibody. The test checks for reactions to 18 common foods, like wheat, milk, and certain fruits. If the test finds high levels of the IgG antibody for a certain food, it means that food is likely causing problems. Therefore, the patient should try to remove that food from their diet.
Many people with IBS struggle to find relief from their stomach pain and discomfort. This new study looked at whether a special blood test could help. The idea was to see if the test could tell people which foods were making their IBS worse. The results were encouraging. When people changed their diets based on what the blood test showed, about 60% of them felt less stomach pain. This is better than the 42% who felt better when they just tried a general diet change. This shows that the blood test might be a useful tool for people with IBS to get real relief.
Many doctors suggest that people with IBS try elimination diets, where they cut out certain foods to see if their symptoms improve. However, these diets can be very hard to follow, because they often require people to cut out a lot of different foods. Doctors are always looking for ways to give patients care that's tailored to their specific needs. In the case of IBS, that means figuring out exactly which foods each person should avoid.
This blood test is a step in that direction. Experts are calling it a move towards "precision nutrition." This means that instead of giving everyone the same diet advice, doctors could use the blood test to create a personalized plan for each patient. While more research is needed, this test brings hope that doctors will soon be able to give much more precise dietary recommendations to those people that suffer from IBS. While this test is yet to be approved by FDA, it could be a world of comfort and ease for people who suffer with IBS.
Credits: Canva
The NHS has released updated guidance for people who are currently taking clonazepam, a commonly prescribed medicine that belongs to the benzodiazepine group. According to the health service, clonazepam is often used to control seizures or fits linked to epilepsy, ease involuntary muscle spasms, and help manage panic disorders. It is also prescribed in some cases for people with restless legs syndrome (RLS). NHS Inform notes that “around 1 in 10 people experience restless legs syndrome at some stage in their life.”
Explaining how the drug works, the NHS says it increases levels of gamma-aminobutyric acid (GABA), a chemical in the brain that has a calming effect. By boosting GABA, clonazepam can reduce anxiety, prevent seizures or fits, and relax tight or overactive muscles.
Clonazepam is only available on prescription and comes as tablets or a liquid. Most adults aged 18 and over can take either form. In certain cases, children as young as one month old may be prescribed clonazepam to treat epilepsy, as per NHS.
That said, there are situations where extra caution is needed. People who are due to have surgery or dental treatment, those who are pregnant, trying to conceive, or who have sleep-related conditions may be advised to stop taking the medicine. However, these are not the only groups the NHS says should be careful.
Clonazepam is not suitable for everyone. Before starting treatment, patients are advised to tell their doctor if they:
Like many medicines, clonazepam can cause side effects. Common effects, which affect more than 1 in 100 people, include disturbed sleep such as vivid dreams, feeling sleepy during the day, light-headedness, dizziness, unsteadiness, and muscle weakness.
When it comes to long-term use, the NHS warns that clonazepam can lead to withdrawal symptoms if taken for a prolonged period. Because of this risk, people who have been prescribed the drug for more than four weeks may have their dose reduced slowly when stopping treatment, rather than stopping suddenly.
The NHS also stresses that this is not a complete list of side effects. Patients are advised to read the information leaflet that comes with their medicine for full details.
Although uncommon, some people may experience serious side effects while taking clonazepam. The NHS advises contacting a doctor or calling 111 immediately if you notice:
In rare cases, clonazepam can trigger a serious allergic reaction known as anaphylaxis.
Disclaimer: This article is for informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified doctor, pharmacist, or healthcare provider before starting, stopping, or changing the dosage of any medication.
Credits: AI Generated
Every winter, people in Delhi prepare themselves for stinging eyes, tight chests and coughs that refuse to go away as thick smog blankets the city. Now, fresh research from Jawaharlal Nehru University (JNU) suggests there is another hidden danger in the polluted air. According to the study, Delhi’s winter smog may also be carrying antibiotic-resistant bacteria, adding to health worries in one of the most polluted cities on the planet.
The research, titled Distribution and antibiotic resistance patterns of airborne staphylococci in urban environments of Delhi, India, was published in Nature – Scientific Reports. It found disturbingly high levels of antibiotic-resistant “superbugs” in both indoor and outdoor air across the city, particularly in winter when pollution levels spike. The findings point to polluted air acting as a possible vehicle for antimicrobial resistance (AMR), which experts already consider one of the gravest global health threats.
As per Indian Express, to understand what people might be breathing in, the researchers collected air samples from a range of everyday locations across Delhi, such as:
Both indoor and outdoor air samples were taken during summer, monsoon and winter to track how bacterial levels and resistance patterns shifted with the seasons.
Across every setting, airborne bacteria levels were far above the World Health Organization’s recommended safe limit for microbial exposure. In some winter samples, bacterial counts exceeded 16,000 colony-forming units per cubic metre, which is more than 16 times higher than the WHO guideline.
What raised even greater concern was the type of bacteria detected. Many belonged to the Staphylococcus group, which includes strains linked to skin infections, pneumonia, bloodstream infections and illnesses commonly acquired in hospitals.
According to the researchers, a large share of the airborne bacteria were identified as methicillin-resistant staphylococci (MRS), meaning they do not respond to commonly prescribed antibiotics. Among these:
Notably, 14 out of 36 multidrug-resistant samples carried the mecA gene, a well-known marker that makes bacteria resistant to methicillin and related antibiotics.
The study showed that levels of airborne drug-resistant bacteria were highest in winter, while monsoon rains led to a sharp drop in outdoor contamination.
Researchers point to a few likely reasons:
On the other hand, rainfall during the monsoon appears to clear bioaerosols from the air, reducing bacterial concentrations outdoors.
Many healthy people may breathe in these bacteria without becoming sick. However, the risk is much higher for:
The researchers note that inhaling drug-resistant bacteria does not automatically lead to infection. Still, it raises the risk of infections that are harder to treat, especially if the bacteria manage to enter vulnerable parts of the body.
Credit: Canva
Researchers say consuming excessive short-form videos on social media may lead to 'brain rot' and cause cognitive decline, increase the risk of depression and worsen behavior in young children and adults.
Named as the 2024 Oxford University Word Of The Year, 'brain rot' is defined as the supposed deterioration of a person’s intellectual state due to overconsumption of low-quality online content such as TikTok videos, Instagram reels and YouTube Shorts.
Until now, brain rot was considered to be merely internet slang but now multiple studies show that the condition can, indeed, impact overall brain health and pave the way for neurodegenerative diseases.
According to a literature review published in Psychological Bulletin, a journal of the American Psychological Association, scientists found links between heavy consumption of such videos and increased symptoms of depression, anxiety, stress and loneliness.
Additionally, the September 2025 study also found that extreme intake of short form videos (SFVs) can worsen cognitive functioning and weakening emotional control as well as regulation.
Moreover, an October 2025 study from Capella University, Minneapolis which summarized 14 studies on SFVs discovered that people who regularly watch videos, ranging between 15 to 60 seconds, were prone to developing 'TikTok Brain' and suffered from low attention spans.
The review noted, "Reports from educators and parents describe teens struggling to focus in class or during prolonged tasks, behavior changes often attributed to constant stimulation from social media scrolling."
Based on these results, Keith Robert Head, a doctoral student in social work at Capella University and study author commented, "So one of the questions that would be interesting for researchers to study is: Are these ADHD diagnoses actually ADHD, or is it an impact from the continued use of short-form video?"
James Jackson, a neuropsychologist at Vanderbilt University Medical Center told NBC News, "The narrative that the only people who are worried about this are grumpy old grandpas who are yelling at you to get off their lawn or the idea that if you’re concerned about this you’re not in step with the times, I think that’s really simplistic."
He also noted that SFVs can be useful through the opportunities it creates for learning as well as community-building and social media users should seek to maintain a balance.
“There are people that engage with short-form videos in ways that are value-added, for sure. But if their engagement is pulling them away from other, more healthy opportunities, if it is isolating them from other people, if it is creating situations where they’re less and less likely to just sit around and be bored, I think that’s a problem," he said.
She further noted that it may take many years of study to determine whether cognitive changes associated with SFVs consumption are reversible and whether they can qualify as an 'addiction'
“It might be too early to claim universal doom,” Gupta said. “The research for alcohol, cigarettes and drugs took 75 years or more to develop. But I would be surprised if, in the next five to 10 years, we do not have similar signs validating the moral panic that we have around short-form videos.”
© 2024 Bennett, Coleman & Company Limited